Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

Ultrasound for molecular imaging and therapy in cancer.

Kaneko OF, Willmann JK.

Quant Imaging Med Surg. 2012 Jun;2(2):87-97.

PMID:
23061039
[PubMed]
Free PMC Article
2.

Microbubble-conjugated vascular endothelial growth factor receptor 2 binding peptide.

Nunn A, Pochon S, Tardy I, Tranquart F, Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Feb 14 [updated 2012 Jul 11].

PMID:
22787696
[PubMed]
Books & Documents
3.

Intravascular targets for molecular contrast-enhanced ultrasound imaging.

Moestue SA, Gribbestad IS, Hansen R.

Int J Mol Sci. 2012;13(6):6679-97. doi: 10.3390/ijms13066679. Epub 2012 Jun 1.

PMID:
22837657
[PubMed]
Free PMC Article
4.

Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics.

Kiessling F, Fokong S, Koczera P, Lederle W, Lammers T.

J Nucl Med. 2012 Mar;53(3):345-8. doi: 10.2967/jnumed.111.099754. Review.

PMID:
22393225
[PubMed - indexed for MEDLINE]
Free Article
5.

Molecular targeted enhanced ultrasound imaging of flk1 reveals diagnosis and prognosis potential in a genetically engineered mouse prostate cancer model.

Xuan JW, Bygrave M, Valiyeva F, Moussa M, Izawa JI, Bauman GS, Klibanov A, Wang F, Greenberg NM, Fenster A.

Mol Imaging. 2009 Jul-Aug;8(4):209-20.

PMID:
19728975
[PubMed - indexed for MEDLINE]
6.

BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.

Pochon S, Tardy I, Bussat P, Bettinger T, Brochot J, von Wronski M, Passantino L, Schneider M.

Invest Radiol. 2010 Feb;45(2):89-95. doi: 10.1097/RLI.0b013e3181c5927c.

PMID:
20027118
[PubMed - indexed for MEDLINE]
7.

Contrast ultrasound and targeted microbubbles: diagnostic and therapeutic applications for angiogenesis.

Smith AH, Fujii H, Kuliszewski MA, Leong-Poi H.

J Cardiovasc Transl Res. 2011 Aug;4(4):404-15. doi: 10.1007/s12265-011-9282-2. Epub 2011 May 3. Review.

PMID:
21538181
[PubMed - indexed for MEDLINE]
8.

Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer.

Pallwein L, Mitterberger M, Gradl J, Aigner F, Horninger W, Strasser H, Bartsch G, zur Nedden D, Frauscher F.

Curr Opin Urol. 2007 Jan;17(1):39-47. Review.

PMID:
17143110
[PubMed - indexed for MEDLINE]
9.

The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55).

Bzyl J, Palmowski M, Rix A, Arns S, Hyvelin JM, Pochon S, Ehling J, Schrading S, Kiessling F, Lederle W.

Eur Radiol. 2013 Feb;23(2):468-75. doi: 10.1007/s00330-012-2594-z. Epub 2012 Aug 10.

PMID:
22878592
[PubMed - indexed for MEDLINE]
10.

Molecular imaging and ultrasound-assisted drug delivery.

Schneider M.

J Endourol. 2008 Apr;22(4):795-802. doi: 10.1089/end.2007.9821. Review.

PMID:
18366315
[PubMed - indexed for MEDLINE]
11.

Contrast ultrasound: general principles and veterinary clinical applications.

Ohlerth S, O'Brien RT.

Vet J. 2007 Nov;174(3):501-12. Epub 2007 Apr 6. Review.

PMID:
17412620
[PubMed - indexed for MEDLINE]
12.

Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.

Anderson CR, Hu X, Zhang H, Tlaxca J, Declèves AE, Houghtaling R, Sharma K, Lawrence M, Ferrara KW, Rychak JJ.

Invest Radiol. 2011 Apr;46(4):215-24. doi: 10.1097/RLI.0b013e3182034fed.

PMID:
21343825
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Fast microbubble dwell-time based ultrasonic molecular imaging approach for quantification and monitoring of angiogenesis in cancer.

Pysz MA, Guracar I, Tian L, Willmann JK.

Quant Imaging Med Surg. 2012 Jun;2(2):68-80. Epub 2012 Jun 15.

PMID:
22943043
[PubMed]
Free PMC Article
14.

Advancement of targeted ultrasound contrast agents and their applications in molecular imaging and targeted therapy.

Yang F, Chen ZY, Lin Y.

Curr Pharm Des. 2013;19(8):1516-27. Review.

PMID:
23270592
[PubMed - indexed for MEDLINE]
15.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
16.

Contrast enhanced transrectal ultrasound for the detection of prostate cancer: a randomized, double-blind trial of dutasteride pretreatment.

Halpern EJ, Gomella LG, Forsberg F, McCue PA, Trabulsi EJ.

J Urol. 2012 Nov;188(5):1739-45. doi: 10.1016/j.juro.2012.07.021. Epub 2012 Sep 19.

PMID:
22998915
[PubMed - indexed for MEDLINE]
17.

Novel contrast-enhanced ultrasound imaging in prostate cancer.

Smeenge M, Mischi M, Laguna Pes MP, de la Rosette JJ, Wijkstra H.

World J Urol. 2011 Oct;29(5):581-7. doi: 10.1007/s00345-011-0747-3. Epub 2011 Aug 17.

PMID:
21847656
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Molecular ultrasound assessment of tumor angiogenesis.

Deshpande N, Pysz MA, Willmann JK.

Angiogenesis. 2010 Jun;13(2):175-88. doi: 10.1007/s10456-010-9175-z. Epub 2010 Jun 12. Review.

PMID:
20549555
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

New developments in ultrasonography for the detection of prostate cancer.

de la Rosette JJ, Aarnink RG.

J Endourol. 2001 Feb;15(1):93-104. Review.

PMID:
11248926
[PubMed - indexed for MEDLINE]
20.

Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.

Pinto PA, Chung PH, Rastinehad AR, Baccala AA Jr, Kruecker J, Benjamin CJ, Xu S, Yan P, Kadoury S, Chua C, Locklin JK, Turkbey B, Shih JH, Gates SP, Buckner C, Bratslavsky G, Linehan WM, Glossop ND, Choyke PL, Wood BJ.

J Urol. 2011 Oct;186(4):1281-5. doi: 10.1016/j.juro.2011.05.078. Epub 2011 Aug 17.

PMID:
21849184
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk